Arbutus Biopharma Corp (ABUS)

SEC filing

Arbutus Biopharma Corp

ABUS · CIK 1447028

4 · Sep 23, 2026 · Director, President and CEO Androski Lindsay exercised options for 253.73K shares; reported 82.53K Common Shares

Director, President and CEO Androski Lindsay exercised options for 253.73K shares; reported 82.53K Common Shares

FORM 4

xslF345X06/wk-form4_1790209942.xmlSEC.gov

Graphics and non-inline formats (not embedded below).